First human tests begin for new drug candidate
NCT ID NCT06774313
Summary
This is a very early, first-in-human study to check the safety of a new drug called ABBV-142 and see how it moves through the body. It involves 73 healthy adult volunteers who will receive a single dose. The main goal is to find a safe dose range and understand the drug's basic behavior before testing it in people with a disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 271899
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.